Science Explorer Back to mapMap
Discussion
Researcher · IntegraGen (France) · France

Jean‐Paul Saraiva

Jean‐Paul Saraiva publishes mostly in Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience, on topics such as Retinal Development and Disorders, Retinal Diseases and Treatments and Photoreceptor and optogenetics research.

OpenAlex
World rank
#2,090,137
of 7,710,434 ranked researchers
Rank in France
#90,654
of 324,115
Works
25
Citations
1.2k
Citations per work
48.4
h-index
14
i10-index 17Top 55% in Molecular Biology
Jean‐Paul Saraiva

What does Jean‐Paul Saraiva research?

Jean‐Paul Saraiva's work is mostly in Biochemistry, Genetics and Molecular Biology (52%), Medicine (25%), Neuroscience (12%).

Life Sciences: 16 works · 63.3% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 51.5% of their workMolecular Biology: 10 works · 39.7% of their workGenetics: 3 works · 11.8% of their workNeuroscience: 3 works · 11.8% of their workCellular and Molecular Neuroscience: 3 works · 11.8% of their workHealth Sciences: 6 works · 25.0% of their workMedicine: 6 works · 25.0% of their workOphthalmology: 4 works · 14.7% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 7.4% of their workPediatrics, Perinatology and Child Health: 1 works · 2.9% of their workEverything else: 3 works · 11.7% of their workTHEIR WORKJean‐Paul Saraiva25works
Life Sciences63%Health Sciences25%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1351.5%
    2. Neuroscience311.8%
    1. Medicine625.0%
  3. Everything else311.7%
  1. 1Molecular Biology40% of their works
  2. 2Ophthalmology15% of their works
  3. 3Cellular and Molecular Neuroscience12% of their works
  4. 4Genetics12% of their works
  5. 5Radiology, Nuclear Medicine and Imaging7% of their works
  6. 6Pediatrics, Perinatology and Child Health3% of their works

Research topics

Which keywords describe Jean‐Paul Saraiva's research?

The keywords of their largest research topics: Macular Degeneration, Gene Therapy, Retinitis Pigmentosa, Oxidative Stress, Diabetic Retinopathy, Retinal Pigment Epithelium, Channelrhodopsin and Optogenetics.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Macular Degeneration262 topics
  2. Gene Therapy171 topic
  3. Retinitis Pigmentosa171 topic
  4. Oxidative Stress132 topics
  5. Diabetic Retinopathy91 topic
  6. Retinal Pigment Epithelium91 topic
  7. Channelrhodopsin71 topic
  8. Optogenetics71 topic
  9. Mitochondria41 topic
  10. Reactive Oxygen Species41 topic
  11. Macular Hole31 topic
  12. Muscle Regeneration31 topic
  13. Skeletal Muscle Atrophy31 topic
  14. Vitreoretinal Surgery31 topic
  15. Endocytosis21 topic
  16. Fragile X Syndrome21 topic
  17. Membrane Fusion21 topic
  18. Rett Syndrome21 topic

Where does Jean‐Paul Saraiva work?

Jean‐Paul Saraiva's main affiliation in the publication record is IntegraGen (France), France.

How many publications and citations does Jean‐Paul Saraiva have?

OpenAlex counts 25 works and 1,210 citations for Jean‐Paul Saraiva, an h-index of 14, ranking #2,090,137 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jean‐Paul Saraiva. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.